The causative gene of Cystic Fibrosis (CF) is the Cystic Fibrosis Transmembrane conductance Regulator (CFTR). Although monogenic, CF has a complex genotype – phenotype relationship mainly originated by the high number of CFTR variants, the challenging mutational analysis, the incomplete functional knowledge and the variable clinical outcome of most variants, the action of modifier genes. This complexity affects diagnosis, prognosis and precision therapy. A correct and complete genetic analysis is crucial for all these aspects. The Consensus Document 2019 on the genetic analysis of CF (1S) provides a guidance to practitioners for the appropriate request and proper use of genetic testing in CF, as well as for the correct interpretation of the test result. It is to be hoped that the broad sharing achieved between the scientific societies involved can standardize the approach at national level and can improve the usefulness of the information provided to users, as part of a continuous process of improvement.

Presentation of the Consensus Document 2019 on the genetic analysis of Cystic Fibrosis.|Consensus 2019 per l'analisi genetica in Fibrosi Cistica: Presentazione del Documento / Lucarelli, M.; Angioni, A.; Baffico, M.; Bombieri, C.; Bonizzato, A.; Borgo, G.; Castaldo, G.; Castellani, C.; Centrone, C.; Coiana, A.; D'Apice, M. R.; Girgenti, C. D.; Egiziano, S.; Favarato, M.; Ferlisi, A.; Melotti, P.; Minicucci, L.; Pelo, E.; Ragusa, A.; Ravani, A.; Savoldi, G.; Seia, M.; Termini, L.. - In: BIOCHIMICA CLINICA. - ISSN 0393-0564. - 44:4(2020), pp. 397-399. [10.19186/BC_2020.074]

Presentation of the Consensus Document 2019 on the genetic analysis of Cystic Fibrosis.|Consensus 2019 per l'analisi genetica in Fibrosi Cistica: Presentazione del Documento

Lucarelli M.
;
2020

Abstract

The causative gene of Cystic Fibrosis (CF) is the Cystic Fibrosis Transmembrane conductance Regulator (CFTR). Although monogenic, CF has a complex genotype – phenotype relationship mainly originated by the high number of CFTR variants, the challenging mutational analysis, the incomplete functional knowledge and the variable clinical outcome of most variants, the action of modifier genes. This complexity affects diagnosis, prognosis and precision therapy. A correct and complete genetic analysis is crucial for all these aspects. The Consensus Document 2019 on the genetic analysis of CF (1S) provides a guidance to practitioners for the appropriate request and proper use of genetic testing in CF, as well as for the correct interpretation of the test result. It is to be hoped that the broad sharing achieved between the scientific societies involved can standardize the approach at national level and can improve the usefulness of the information provided to users, as part of a continuous process of improvement.
2020
Cystic Fibrosis; consensus; genetics
01 Pubblicazione su rivista::01a Articolo in rivista
Presentation of the Consensus Document 2019 on the genetic analysis of Cystic Fibrosis.|Consensus 2019 per l'analisi genetica in Fibrosi Cistica: Presentazione del Documento / Lucarelli, M.; Angioni, A.; Baffico, M.; Bombieri, C.; Bonizzato, A.; Borgo, G.; Castaldo, G.; Castellani, C.; Centrone, C.; Coiana, A.; D'Apice, M. R.; Girgenti, C. D.; Egiziano, S.; Favarato, M.; Ferlisi, A.; Melotti, P.; Minicucci, L.; Pelo, E.; Ragusa, A.; Ravani, A.; Savoldi, G.; Seia, M.; Termini, L.. - In: BIOCHIMICA CLINICA. - ISSN 0393-0564. - 44:4(2020), pp. 397-399. [10.19186/BC_2020.074]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1679509
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact